在健康和神经疾病中α-synuclein的多方面的表现
Min Wang1, Yourui Xu2, Shengming Wang3
1Min Wang, Guangxi Key Laboratory of Brain and Cognitive Neuroscience, Guilin Medical University, Guilin, Guangxi 541199, China.
Neuroscience
|February 25, 2026
概括
错误折叠的α-synuclein (αSyn) 通过破坏细胞功能导致神经退行. 了解 αSyn 的理解
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生物化学
- 细胞生物学 细胞生物学
背景情况:
- 在正常情况下,α-synuclein (αSyn) 对突触功能至关重要.
- 错误折叠和聚合的αSyn是神经退行性疾病 (如帕金森病) 的标志.
- 病理性αSyn破坏细胞蛋白质质量控制系统,导致神经元死亡.
研究的目的:
- 审查αSyn.的生理和病理作用.
- 探索αSyn聚合和传播的机制.
- 讨论针对αSyn.的治疗策略.
主要方法:
- 文献综述和对αSyn.当前研究的综合.
- 对αSyn参与蛋白质降解途径的分析.
- 检查αSyn在细胞间传播和相分离中的作用.
主要成果:
- αSyn的正常功能涉及突触调节.
- 疾病状态包括αSyn聚合,蛋白质稳定性受损和突触功能障碍.
- 翻译后的修改和液-液相分离影响αSyn病理.
结论:
- 对αSyn机制的全面理解对于治疗α-synucleinopathies至关重要.
- 针对聚合的αSyn提供了治疗潜力.
- 开发针对α-synucleinopathies的诊断生物标志物是一个关键目标.
相关概念视频
Neural Regulation
43.8K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.8K
Parkinson's Disease: Overview
2.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K
Amyloid Fibrils
12.2K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
12.2K
Amyloid Fibrils
6.8K
6.8K
Alzheimer's Disease: Overview
1.9K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.9K
Lysosomal Hydrolases
4.7K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.7K


